previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00039 | 1 | BA_1960 | 30256617 | aminoglycoside 6-adenylyltransferase, pu... | 290 | Virulence | October 2007 | 2PBE | 37.9% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01134 | 1 | BA_2001 | 30256654 | intracellular serine protease | 316 | Drug Target Function | March 2008 | 1AK9 | 38% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00040 | 1 | BA_2042 | 46395770 | Metallothiol transferase fosB 1 (Fosfomy... | 138 | Virulence | October 2007 | 1NPB | 42.8% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01112 | 1 | BA_2064 | 30256713 | csaA | chaperone CsaA | 109 | Conserved Gene / Pathway | March 2008 | 2NZH | 72.5% | Bacillus anthracis | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||
| IDP01202 | 1 | BA_2079 | 30256728 | dal-2 | alanine racemase | 391 | Drug Target Function | March 2008 | 1BD0 | 40.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01203 | 1 | BA_2083 | 30256732 | glycosyltransferase, MGT family | 402 | Conserved Gene / Pathway | March 2008 | 2IYA | 27.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00010 | 1 | BA_2144 | 30256791 | uroporphyrin-III C-methyltransferase, pu... | 474 | Drug Target Homolog | October 2007 | 1PJQ | 24.1% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Heme, porphyrin, and cobalamin | ||||||||||||||||||
| IDP00011 | 1 | BA_2222 | 30256868 | alcohol dehydrogenase, iron-containing | 392 | Drug Target Homolog | October 2007 | 3BFJ | 34.9% | Bacillus anthracis | Energy metabolism | Fermentation | ||||||||||||||||||
| IDP01258 | 1 | BA_2238 | 30256883 | pbpC | penicillin-binding protein 3 | 661 | Drug Target Function | March 2008 | 1MWR | 34.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01107 | 1 | BA_2250 | 30256894 | heat shock protein, Hsp20 family | 153 | Conserved Gene / Pathway | March 2008 | 1SHS | 23.5% | Bacillus anthracis | Protein fate | Protein folding and stabilization | ||||||||||||||||||
| IDP01204 | 1 | BA_2274 | 30256914 | glycosyl transferase, group 2 family pro... | 406 | Essential Gene | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01243 | 1 | BA_2345 | 30256982 | penicillin-binding protein 1A | 820 | Drug Target Function | March 2008 | 2OLU | 29.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01205 | 1 | BA_2369 | 30257005 | dhbC | isochorismate synthase DhbC | 399 | Drug Target Function | March 2008 | 1K0E | 23.3% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Other | |||||||||||||||||
| IDP00041 | 1 | BA_2409 | 30257040 | chloramphenicol acetyltransferase | 216 | Virulence | October 2007 | 1QCA | 41.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01206 | 1 | BA_2446 | 30257076 | N-acetylmuramoyl-L-alanine amidase, fami... | 245 | Conserved Gene / Pathway | March 2008 | 1XOV | 26.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01244 | 1 | BA_2504 | 30257132 | penicillin-binding protein | 588 | Drug Target Function | March 2008 | 1MWR | 23.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00042 | 1 | BA_2507 | 30257134 | bla1 | beta-lactamase | 309 | Virulence | October 2007 | 1W7F | 53.7% | Bacillus anthracis | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP01253 | 1 | BA_2575 | 30257197 | penicillin-binding protein, putative | 481 | Drug Target Function | March 2008 | 2QMI | 20% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01207 | 1 | BA_2610 | 39930865 | D-alanine--D-alanine ligase (D-alanylala... | 304 | Conserved Gene / Pathway | March 2008 | 1E4E | 37.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00043 | 1 | BA_2629 | 30257246 | acetyltransferase, CYSE/LACA/LPXA/NODL f... | 210 | Virulence | October 2007 | 1KHR | 59.5% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01245 | 1 | BA_2637 | 30257254 | penicillin-binding protein | 708 | Drug Target Function | March 2008 | 1MWR | 21% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01208 | 1 | BA_2638 | 30257255 | glycosyl transferase, putative | 387 | Essential Gene | March 2008 | 2IYA | 27.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01246 | 1 | BA_2648 | 30257265 | penicillin-binding protein | 712 | Drug Target Function | March 2008 | 1QME | 29.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01209 | 1 | BA_2650 | 30257267 | penicillin-binding protein | 340 | Drug Target Function | March 2008 | 2QMI | 27.1% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01105 | 1 | BA_2788 | 67460529 | ATP-dependent Clp protease proteolytic s... | 193 | Drug Target Function | March 2008 | 2ZL0 | 65.8% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01210 | 1 | BA_2805 | 30257409 | glycosyl hydrolase, family 25, putative ... | 268 | Conserved Gene / Pathway | March 2008 | 2NW0 | 51.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01174 | 1 | BA_2823 | 30257425 | hypothetical protein BA_2823 | 375 | Drug Target Function | March 2008 | Bacillus anthracis | ||||||||||||||||||||||
| IDP01175 | 1 | BA_2825 | 30257427 | peptidase M3 family protein | 548 | Drug Target Function | March 2008 | 3CE2 | 23.4% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01176 | 1 | BA_2869 | 30257466 | peptidase, putative | 358 | Drug Target Function | March 2008 | 3CE2 | 22.9% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00044 | 1 | BA_2930 | 30257522 | aacC7 | aminoglycoside N3-acetyltransferase | 265 | Virulence | October 2007 | 3E4F | 100% | Bacillus anthracis | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00012 | 1 | BA_2953 | 61211623 | 3-phosphoshikimate 1-carboxyvinyltransfe... | 429 | Drug Target Homolog | October 2007 | 1RF4 | 51.3% | Bacillus anthracis | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP01211 | 1 | BA_2958 | 30257549 | chorismate mutase/phospho-2-dehydro-3-de... | 358 | Drug Target Function | March 2008 | 1VS1 | 39.1% | Bacillus anthracis | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP01212 | 1 | BA_3024 | 30257611 | glycosyl transferase, group 2 family pro... | 490 | Essential Gene | March 2008 | 3E25 | 9.8% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00045 | 1 | BA_3111 | 30257692 | aminoglycoside phosphotransferase family... | 292 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP00046 | 1 | BA_3165 | 30257736 | bromoperoxidase | 278 | Virulence | October 2007 | 1BRO | 49.3% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00047 | 1 | BA_3185 | 30257752 | streptothricin acetyltransferase, putati... | 184 | Virulence | October 2007 | 2I79 | 25.5% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01247 | 1 | BA_3214 | 30257780 | penicillin-binding protein, putative | 691 | Drug Target Function | March 2008 | 2QMI | 14.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01213 | 1 | BA_3251 | 30257808 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 329 | Drug Target Function | March 2008 | 2EBD | 34.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00013 | 1 | BA_3254 | 30257811 | LPXTG-motif cell wall anchor domain prot... | 372 | Drug Target Homolog | October 2007 | 1I84 | 18.3% | Bacillus anthracis | Cell envelope | Other | ||||||||||||||||||
| IDP00048 | 1 | BA_3330 | 30257875 | beta-lactam antibiotic acylase family pr... | 796 | Virulence | October 2007 | 1KEH | 22.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00049 | 1 | BA_3355 | 30257898 | thiol-activated cytolysin | 512 | Virulence | October 2007 | 1PFO | 67.4% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00050 | 1 | BA_3443 | 30257983 | enhancin family protein | 742 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP01214 | 1 | BA_3460 | 30257999 | cfa | cyclopropane-fatty-acyl-phospholipid syn... | 390 | Drug Target Function | March 2008 | 1TPY | 25.1% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00051 | 1 | BA_3469 | 30258008 | phenazine biosynthesis protein, PhzF fam... | 299 | Virulence | October 2007 | 3EDN | 100% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00052 | 1 | BA_3500 | 30258038 | bla2 | beta-lactamase II | 256 | Virulence | October 2007 | 1BC2 | 81.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP01215 | 1 | BA_3506 | 30258044 | penicillin-binding protein, putative | 345 | Drug Target Function | March 2008 | 2QMI | 25.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00053 | 1 | BA_3536 | 30258071 | phenazine biosynthesis protein, PhzF fam... | 285 | Virulence | October 2007 | 1QY9 | 31.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01248 | 1 | BA_3554 | 30258085 | penicillin-binding protein, putative | 377 | Drug Target Function | March 2008 | 2QMI | 22.3% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01216 | 1 | BA_3577 | 30258105 | glycosyl transferase, group 1 family pro... | 270 | Essential Gene | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP00054 | 1 | BA_3600 | 30258128 | acetyltransferase, CYSE/LACA/LPXA/NODL f... | 185 | Virulence | October 2007 | 1KHR | 42.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01217 | 1 | BA_3695 | 30258216 | S-layer protein, putative | 510 | Drug Target Function | March 2008 | Bacillus anthracis | Cell envelope | Surface structures | ||||||||||||||||||||
| IDP00055 | 0 | BA_3696 | 30258217 | blasticidin S deaminase, putative | 142 | Virulence | October 2007 | 3B8F | 99.3% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01218 | 1 | BA_3712 | 73919984 | Histidine ammonia-lyase (Histidase) | 505 | Drug Target Function | March 2008 | 1B8F | 42.2% | Bacillus anthracis | Energy metabolism | Amino acids and amines | ||||||||||||||||||
| IDP01157 | 1 | BA_3749 | 60390552 | Phosphonates import ATP-binding protein ... | 257 | Conserved Gene / Pathway | March 2008 | 1F3O | 36.6% | Bacillus anthracis | Transport and binding proteins | Other | ||||||||||||||||||
| IDP01117 | 1 | BA_3754 | 33301235 | LexA repressor | 206 | Conserved Gene / Pathway | March 2008 | 1JHF | 38.3% | Bacillus anthracis | DNA metabolism | DNA replication, recombination, and repair | ||||||||||||||||||
| IDP01219 | 1 | BA_3767 | 30258283 | prophage LambdaBa01, N-acetylmuramoyl-L-... | 310 | Drug Target Function | March 2008 | 1YB0 | 39% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01108 | 1 | BA_3860 | 30258377 | copper-ion-binding protein | 68 | Conserved Gene / Pathway | March 2008 | 1K0V | 61.8% | Bacillus anthracis | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP00056 | 1 | BA_3898 | 30258412 | choloylglycine hydrolase family protein ... | 328 | Virulence | October 2007 | 2OQC | 48.8% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00057 | 1 | BA_3900 | 30258414 | lantibiotic biosynthesis DNA-binding res... | 220 | Virulence | October 2007 | 2GWR | 34.1% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00058 | 1 | BA_3903 | 30258417 | bacteriocin ABC transporter, ATP-binding... | 234 | Virulence | October 2007 | 1OXS | 32.5% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01135 | 1 | BA_3911 | 30258425 | renal dipeptidase family protein | 307 | Drug Target Function | March 2008 | 1ITQ | 23.8% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00014 | 1 | BA_3915 | 17368674 | Protein recA (Recombinase A) | 343 | Drug Target Homolog | October 2007 | 1UBC | 65.6% | Bacillus anthracis | DNA metabolism | DNA replication, recombination, and repair | ||||||||||||||||||
| IDP01136 | 1 | BA_3942 | 30258453 | zinc protease, insulinase family | 413 | Drug Target Function | March 2008 | 1HR6 | 29.5% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01137 | 1 | BA_3968 | 47605672 | ATP-dependent protease hslV | 180 | Drug Target Function | March 2008 | 1YYF | 78.9% | Bacillus anthracis | Protein fate | Protein folding and stabilization | ||||||||||||||||||
| IDP01220 | 1 | BA_3983 | 30258492 | ffH | signal recognition particle protein | 449 | Conserved Gene / Pathway | March 2008 | 2J28 | 51.7% | Bacillus anthracis | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||
| IDP01221 | 1 | BA_3990 | 30258499 | fabD | malonyl CoA-acyl carrier protein transac... | 314 | Drug Target Function | March 2008 | 1MLA | 44.9% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00059 | 1 | BA_4013 | 30258522 | fibronectin/fibrinogen-binding protein, ... | 569 | Virulence | October 2007 | 3DOA | 22.5% | Bacillus anthracis | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP01118 | 1 | BA_4030 | 81837831 | Bifunctional protein pyrR [Includes: Pyr... | 180 | Conserved Gene / Pathway | March 2008 | 1A3C | 73.9% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Pyrimidine ribonucleotide biosynthesis | ||||||||||||||||||
| IDP01122 | 1 | BA_4045 | 30258552 | ftsZ | cell division protein FtsZ | 386 | Conserved Gene / Pathway | March 2008 | 2VAM | 78.8% | Bacillus anthracis | Cellular processes | Cell division | |||||||||||||||||
| IDP00015 | 1 | BA_4048 | 47605856 | UDP-N-acetylenolpyruvoylglucosamine redu... | 301 | Drug Target Homolog | October 2007 | 1HSK | 39.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01222 | 1 | BA_4049 | 33301352 | UDP-N-acetylglucosamine--N-acetylmuramyl... | 364 | Drug Target Function | March 2008 | 1F0K | 31.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01223 | 1 | BA_4051 | 60390084 | UDP-N-acetylmuramoylalanine--D-glutamate... | 450 | Conserved Gene / Pathway | March 2008 | 1E0D | 34.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00016 | 1 | BA_4053 | 46576983 | UDP-N-acetylmuramoyl-L-alanyl-D-glutamat... | 491 | Drug Target Homolog | October 2007 | 1E8C | 35% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01224 | 1 | BA_4054 | 30258561 | sporulation specific penicillin-binding ... | 638 | Drug Target Function | March 2008 | 1PYY | 26.6% | |||||||||||||||||||||